Sunrun stock slides as RUN lags solar peers with jobs report, Goldman conference in focus

Sunrun stock slides as RUN lags solar peers with jobs report, Goldman conference in focus

New York, Jan 5, 2026, 14:26 EST — Regular session

  • Sunrun shares down about 6% in afternoon trade, underperforming most solar peers
  • Investors watch for comments at Goldman Sachs Energy, Cleantech & Utilities Conference this week
  • Friday’s U.S. jobs report looms as markets reassess the interest-rate path

Sunrun Inc shares fell 5.6% on Monday, a sharp underperformer in U.S. solar, as investors weighed fresh U.S. economic data and looked ahead to a key jobs report later this week. The stock was down $1.08 at $18.36 in afternoon trade.

The move matters because Sunrun’s rooftop solar business leans heavily on financing, and shifts in interest-rate expectations can quickly change customer economics and investor appetite for the sector. Traders were also scanning for any read-through on demand and pricing as the first full week of 2026 gets underway. Reuters

The broader market was higher, with Wall Street’s main indexes rising as investors rotated into financials and energy stocks. That left Sunrun’s drop looking more company-and-sector specific than a simple risk-off move. Reuters

Elsewhere in solar, Enphase Energy and SolarEdge Technologies were both up about 1%, while First Solar fell about 2%. Sunrun traded between $17.77 and $20.00 on the day, underscoring the stock’s volatility.

Investors are also watching for any remarks from Sunrun executives around the Goldman Sachs Energy, Cleantech & Utilities Conference in Miami, scheduled for Jan. 5–7, according to the company’s investor calendar. Sunrun Inc.

On the macro front, U.S. manufacturing contracted more than expected in December, extending a months-long slump, a Reuters report said. The Institute for Supply Management’s manufacturing PMI fell to 47.9; readings below 50 signal contraction. Reuters

Inflation remains the other pressure point for rate-sensitive stocks. ISM’s “prices paid” index — a gauge of input costs — held at 58.5, which the report said has helped keep inflation above the Federal Reserve’s 2% target. Reuters

“While a less fluid trade environment and somewhat more favorable business tax environment are positives for activity, we remain cautious on the extent of recovery in traditional cap-ex categories this year,” Shannon Grein, an economist at Wells Fargo, said in the Reuters report. Reuters

For Sunrun, rates matter because many customers opt for leases or long-term power contracts rather than buying systems outright. Higher borrowing costs can lift monthly payments and tighten the financing markets the industry relies on, which tends to hit valuation multiples when rate expectations shift.

But the stock’s direction is not locked in. Any upbeat tone from management at this week’s conference — or signs that inflation pressures are easing — could help stabilize solar names, while a hotter-than-expected jobs print could revive “higher for longer” rate worries and keep pressure on the group. Sunrun Inc.

Stock Market Today

  • McCormick to Invest $750 Million for Majority Control of McCormick de Mexico
    January 8, 2026, 7:21 AM EST. McCormick & Company will pay $750 million to raise its stake in McCormick de Mexico to 75% from 50%, gaining majority control of the joint venture formed in 1947 with Grupo Herdez. The move broadens McCormick's footprint in Mexico and could enable more-direct strategic and operational decisions in the market. The company said the deal is expected to be accretive to net sales, adjusted operating margin, and adjusted earnings per share from 2026 onward, while deepening its regional presence and accelerating expansion across Latin America. McCormick de Mexico sells condiments, sauces, spices, and teas, generating roughly $800 million in annual net sales with mid-single-digit growth. Bank of America analyst Peter Galbo called the transaction attractive and aligned with McCormick's longer-term geographic and product-expansion goals.
Viking Therapeutics stock sinks as Novo’s Wegovy pill debut resets obesity-drug pricing
Previous Story

Viking Therapeutics stock sinks as Novo’s Wegovy pill debut resets obesity-drug pricing

Natural gas price stock UNG slides as Henry Hub futures tumble 5% on warm U.S. outlook
Next Story

Natural gas price stock UNG slides as Henry Hub futures tumble 5% on warm U.S. outlook

Go toTop